The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 15, 2020

Filed:

Jun. 02, 2017
Applicant:

Cadent Therapeutics, Inc., Cambridge, MA (US);

Inventors:

Birgitte Langer Eriksen, Farum, DK;

Magnus Gustafsson, Frederiksberg, DK;

Charlotte Hougaard, Ballerup, DK;

Thomas Amos Jacobsen, Oested, DK;

Martin R. Jefson, Stonington, CT (US);

Gregg F. Keaney, Lexington, MA (US);

Jessica Klein, Copenhagen, DK;

Janus Schreiber Larsen, Holbæk, DK;

John A. Lowe, III, Stonington, CT (US);

John M. McCall, Boca Grande, FL (US);

Dorte Strøbæk, Farum, DK;

Nadia Lybøl von Schoubye, Copenhagen, DK;

Assignee:

Cadent Therapeutics, Inc., Cambridge, MA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07D 401/04 (2006.01); C07D 413/14 (2006.01); C07D 403/04 (2006.01); C07D 409/14 (2006.01); C07D 417/04 (2006.01); C07D 491/10 (2006.01); C07D 498/08 (2006.01); C07D 403/14 (2006.01); C07D 405/14 (2006.01); C07D 487/04 (2006.01); C07D 417/14 (2006.01); C07D 487/08 (2006.01); C07D 401/14 (2006.01); C07D 471/04 (2006.01);
U.S. Cl.
CPC ...
C07D 401/04 (2013.01); C07D 401/14 (2013.01); C07D 403/04 (2013.01); C07D 403/14 (2013.01); C07D 405/14 (2013.01); C07D 409/14 (2013.01); C07D 413/14 (2013.01); C07D 417/04 (2013.01); C07D 417/14 (2013.01); C07D 471/04 (2013.01); C07D 487/04 (2013.01); C07D 487/08 (2013.01); C07D 491/10 (2013.01); C07D 498/08 (2013.01);
Abstract

Provided are novel compounds of Formula (I): and pharmaceutically acceptable salts thereof, which are useful for treating a variety of diseases, disorders or conditions which can be affected by potassium channel modulation. Also provided are pharmaceutical compositions comprising the novel compounds of Formula (I), pharmaceutically acceptable salts thereof, and methods for their use in treating one or more diseases, disorders or conditions, associated with potassium channels.


Find Patent Forward Citations

Loading…